AAAAAA

   
Results: 1-9 |
Results: 9

Authors: SCHLAGETER MH LARGHERO J CASSINAT B TOUBERT ME BORSCHNECK C RAIN JD
Citation: Mh. Schlageter et al., SERUM CARCINOEMBRYONIC ANTIGEN, CANCER ANTIGEN-125, CANCER ANTIGEN-15-3, SQUAMOUS-CELL CARCINOMA, AND TUMOR-ASSOCIATED TRYPSIN-INHIBITOR CONCENTRATIONS DURING HEALTHY PREGNANCY, Clinical chemistry, 44(9), 1998, pp. 1995-1998

Authors: CASSINAT B CHEVRET S BALITRAND N ZASSADOWSKI F BARBEY C RAIN JD DEGOS L FENAUX P CHOMIENNE C
Citation: B. Cassinat et al., ACUTE PROMYELOCYTIC LEUKEMIA - PROGNOSTIC-SIGNIFICANCE OF PML-RAR-ALPHA TYPING AND IN-VITRO ATRA DIFFERENTIATING EFFICIENCY ON LEUKEMIC BLASTS, British Journal of Haematology, 102(1), 1998, pp. 14-14

Authors: JEAN D RODRIGUESLIMA F CASSINAT B HERMANN J CABANE J FRADE R
Citation: D. Jean et al., COEXPRESSION AND SECRETION OF C3, THE 3RD COMPONENT OF COMPLEMENT ANDA C3-CLEAVING CYSTEINE PROTEINASE IN A HIGHLY METASTATIC HUMAN-MELANOMA CELL-LINE, Immunology letters, 58(2), 1997, pp. 107-112

Authors: BAREL M DRANE P CASSINAT B BALBO M BOUILLIE S FRADE R
Citation: M. Barel et al., IDENTIFICATION OF A NEW DNA-BINDING PROTEIN ANTIGENICALLY AND FUNCTIONALLY RELATED TO THE TUMOR-SUPPRESSOR P53 PROTEIN, Journal of allergy and clinical immunology, 99(1), 1997, pp. 136-136

Authors: RODRIGUESLIMA F JEAN D CASSINAT B HERMANN J FRADE R
Citation: F. Rodrigueslima et al., COEXPRESSION IN A HUMAN-MELANOMA CELL-LINE OF C3, THE 3RD COMPONENT OF COMPLEMENT AND A C3-CLEAVING CYSTEINE PROTEINASE, The FASEB journal, 10(6), 1996, pp. 2566-2566

Authors: CASSINAT B DRANE P BAREL M BALBO M BOUILLIE S FRADE R
Citation: B. Cassinat et al., REGULATION BY EBV OF THE EXPRESSION OF THE 2 INTRACELLULAR PROTEINS WHICH INTERACT WITH THE C3D EBV RECEPTOR (CR-2, CD21) IN HUMAN B-LYMPHOCYTES/, The FASEB journal, 10(6), 1996, pp. 2661-2661

Authors: BALBO M BAREL M BOUILLIE S DRANE P CASSINAT B FRADE R
Citation: M. Balbo et al., PEP34, A SYNTHETIC PEPTIDE WHOSE SEQUENCE CORRESPONDS TO THE INTRACYTOPLASMIC DOMAIN OF THE EPSTEIN-BARR-VIRUS RECEPTOR (CR-2, CD21), REGULATES HUMAN B-LYMPHOCYTE PROLIFERATION TRIGGERED THROUGH CR-2, Molecular immunology, 32(16), 1995, pp. 1295-1298

Authors: BOUILLIE S BAREL M DRANE P CASSINAT B BALBO M HOLERS VM FRADE R
Citation: S. Bouillie et al., EPSTEIN-BARR-VIRUS C3D RECEPTOR (CR2, CD21) ACTIVATED BY ITS EXTRACELLULAR LIGANDS REGULATES PP105 PHOSPHORYLATION THROUGH 2 DISTINCT PATHWAYS, European Journal of Immunology, 25(9), 1995, pp. 2661-2667

Authors: CASSINAT B NICOLAS MH
Citation: B. Cassinat et Mh. Nicolas, COMPARISON OF ANTIBIOTIC COMBINATIONS AGAINST PENICILLIN-RESISTANT PNEUMOCOCCI, Journal of antimicrobial chemotherapy, 34(5), 1994, pp. 785-790
Risultati: 1-9 |